There is no pharmacological reason to expect that commonly prescribed medicinal products used in the treatment of asthma will interact with omalizumabLiterature Literature
the names and the precise activities of all related companies involved in the production and/or sales (export and/or domestic) of the product under investigationLiterature Literature